Cronos Group Inc
πΊπΈXNAS.CRONUnited StatesHealthcare
Price$3.35+0.03 (+0.9%)
Latest anomalies
Negative 2 detected in the last 120 days
- High: 1
- Medium: 3
- Low: 0
Earnings yield: declining while the industry median improves
Return on equity: declining while the industry median improves
Net margin: collapsed against the prior period
PEG ratio: a sudden drop below its trailing quarter average
Free with a Finzer account.
Profile
- Healthcare
- Drug Manufacturers - Specialty & Generic
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- CA22717L1013
- CUSIP
- 226903102
Company
- Employees
- 459
- Headquarters
- Stayner, United States
- Website
- https://thecronosgroup.com
Market
- Shares outstanding
- 368.4M
- Market cap
- $1.02B
Key dates
- Next earnings
- Nov 5, 2026
Highlights
- Market cap
- $1.02B
- EPS LTM
- $0.05
- P/E LTM
- 53.97
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $130.28M+28.01%up year on year
- Net income
- $18.49M+132.19%up year on year
- Gross margin
- 32.74%+99.98%up year on year
- Free cash flow
- -$9.41M-184.46%down year on year
Latest news
Business summary
Cronos Group Inc is a company in the healthcare sector, listed on Nasdaq (United States) under the ticker CRON. Its market capitalisation is $1.02B, from 368.4M shares outstanding, as of . Across the 250 trading sessions to the shares traded between $2.28 and $3.60, and the last close of $3.35 sits 81% of the way up that range. The company is headquartered in Stayner, United States, and employs about 459 people. This is the Nasdaq listing of Cronos Group Inc; its primary listing is CRON on Toronto Stock Exchange.
Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. It offers dried flowers, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brand names. The company is based in Stayner, Canada.